About RevBio
RevBio is a private company based in Lowell, Massachusetts. It has reported $32,499,787 raised in three offerings on Form D since January 2019. Its chief executive is Brian Hess.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 24, 2023 | May 18, 2023amended Oct 2, 2026 | $14,988,157of $15.0M target | 72 | $208K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗3 earlier filings |
| Jun 1, 2021 | Jun 11, 2021amended May 24, 2022 | $9,011,630of $10.2M target | 34 | $265K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 21, 2018 | Jan 7, 2019 | $8,500,000of $9.5M target | 71 | $119K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $32,499,787 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on RevBio's Form D filed Oct 2, 2026.
DA
